Sağlık Bilimleri Üniversitesi
Ankara, Turkey (Türkiye)
NCT Number: NCT06510686
In Chronic Obstructive Pulmonary Disease (COPD), a mismatch develops between the respiratory system's demand and the functional capacity of respiratory muscles due to the combination of local and systemic factors increasing the respiratory workload. This results in impaired coordination of muscle groups, leading to muscle dysfunction. Respiratory muscle dysfunction is a significant determinant of life expectancy in COPD. Additionally, respiratory muscles unable to cope with increased workloads lead to impaired respiratory functions and reduced exercise capacity.
It is widely accepted that appropriate training of respiratory muscles can increase their strength, endurance, and their close relationship with lung volume capacities. Besides their role in respiration, respiratory muscles also contribute to postural function and core stabilization. Studies on respiratory muscle training in COPD have primarily focused on inspiratory muscle strength training, neglecting the core stabilization function of respiratory muscles. However, optimal gains in a muscle can only be achieved with training tailored to its functional characteristics. Therefore, a comprehensive training program should be developed considering the multifunctional nature of respiratory muscles. Studies published in healthy individuals and different patient populations demonstrate that core training can improve lung functions. The aim of this study is to compare the effects of inspiratory muscle training and core stabilization training on diaphragm activation, inspiratory muscle strength, functional capacity, respiratory functions, physical activity, and quality of life in individuals with COPD.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Interventional
Not applicable
Ankara, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
exercises to strengthen inspiratory muscles
Other names: Normal breath exercises and İnspiratory muscle training
exercises to strengthen inspiratory and core muscles
Other names: Normal breath exercises and İnspiratory muscle training and Core Stabilization
Time frame: 8 weeks
Maximal Inspiratory Pressure (MIP) (cmH2O),
Time frame: 8 weeks
surface EMG (TLC from FRC (TLC maneuver)(cmH2O)
Time frame: 8 weeks
Spirometry, FEV1 (lt)
Time frame: 8 weeks
Spirometry, FVC (lt)
Time frame: 8 weeks
Spirometry, PEF (lt/sn)
Time frame: 8 weeks
Spirometry, FEV1/FVC %
Time frame: 8 weeks
Spirometry, MVV(L/min)
Time frame: 8 weeks
Six Minute Walking Test (6MVT) (m)
Time frame: 8 weeks
MMRC Dyspnea Scale (Scores range from 0 to 4)
Time frame: 8 week
IPAQ (MET/minute)
Time frame: 8 week
SGRQ (Scores range from 0 to 100)
Time frame: 8 week
1 minute sit to stand ( how many times sit and stand during 1 minute)
Time frame: 8 week
Mcgill Endurance Tests For Trunk Flexion (sec)
Time frame: 8 week
Mcgill Endurance Tests For Trunk Extension (sec)
Time frame: 8 week
Mcgill Endurance Tests For Side Bridge (sec)
Mustafa Ertuğrul Yaşa
Other
Comparison of the Effects of Core Stabilization and Inspiratory Muscle Training on Diaphragm Activation, Inspiratory Muscle Strength, Functional Capacity, Respiratory Functions, Physical Activity and Quality of Life in Patients With COPD
Acronym: COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03927820
Asthma, Bronchial Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06614959
Bronchial Diseases, Bronchitis
Montreal, Quebec, Canada
View Trial DetailsNCT04754490
COPD, Chronic Disease
Abercynon, Wales, United Kingdom
View Trial DetailsNCT06336252
Arthritis, Basal Ganglia Diseases
Copenhagen, Denmark
View Trial Details